Form 4: Coya Therapeutics Director Lee Ann Acquires Additional Shares

Director Lee Ann reported the acquisition of 1,000 shares of Coya Therapeutics, Inc. common stock through a spouse's IRA.

Summary

• On August 22, 2023, Lee Ann, a director of Coya Therapeutics, Inc., acquired 1,000 shares of common stock.
• The shares were purchased at a weighted average price of $3.62 per share, with individual prices ranging from $3.59 to $3.63.
• The transaction was executed through the IRA of Lee Ann's spouse.
• Following the transaction, Lee Ann indirectly owns 17,479 shares of Coya Therapeutics common stock through the spouse's IRA.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports a transaction. It doesn't inherently indicate positive or negative sentiment towards the company's prospects.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. This particular filing indicates a director's continued investment in the company, albeit indirectly through a spouse's IRA.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder confidence as it indicates a director's continued investment in the company.

Key Dates